Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Pseudolaric acid B
Cat. No.:
OB0225LY-0243
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Pseudolaric acid B is a natural diterpenoid compound and isolated from Pseudolarix kaempferi.
Synonym:
82508-31-4; (2E,4E)-5-((3R,4S,4aS,9aR)-4a-Acetoxy-7-(methoxycarbonyl)-3-methyl-1-oxo-3,4,4a,5,6,9-hexahydro-1H-4,9a-ethanocyclohepta[c]pyran-3-yl)-2-methylpenta-2,4-dienoic acid; (2E,4E)-5-[(1R,7S,8S,9R)-7-Acetyloxy-4-methoxycarbonyl-9-methyl-11-oxo-10-oxatricyclo[6.3.2.01,7]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoic acid
CAS No.:
82508-31-4
Compound CID:
6475943
Formula:
C23H28O8
Formula Weight:
432.46
Specification
Source:
Pseudolarix kaempferi
Relative Density:
1.2108 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Pseudolaric acid B can be used in pharmacological studies as a basis for the study of anti-tumor and anti-microbial activity.
Library Information
Targets:
p38 MAPK; Ferroptosis; HBV
Pathways:
Microbiology/Virology; MAPK; Apoptosis; Autophagy
Plate Number:
AOCL-4
Plate Location:
a8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 115.62 mM
ALogP:
2.793
HBA_Count:
7
HBD_Count:
0
Rotatable Bond:
7
